https://www.selleckchem.com/products/sh-4-54.html
07, 95% CI 0.91-1.27 and 1.22, 95% CI 1.03-1.45, respectively) with evidence of a positive linear trend (p = .015). These data indicate that eGFR variability predict changes in the risk of major clinical outcomes in T2D. The purpose of this study was to determine the relationship between PSS, PH, FCP and QoL of oncology patients. In this descriptive-correlational study, 340 oncology patients were selected with convenience sampling method from the hospitals in Tehran 2018-2019. Data were collected using, "PSS," "PH," "FCP" and "European
Beğen
Yorum Yap
Paylaş
